Niedobór witaminy K u niemowląt chorych na mukowiscydozę

• Authors: Krzyżanowska Patrycja , Lisowska Aleksandra , Woś Halina , Trawińska-Bartnicka Maria , Bober Lyudmyla , Rohovyk Nataliya , Rachel Marta , Walkowiak Jarosław
• Languages of publication: PL

Keywords

PL

mukowiscydoza, witamina K; niekarboksylowana protrombina

• Publisher: Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
• Journal: Family Medicine & Primary Care Review
• Year: 2011
• Issue: 2
• Pages: 171-173

Contributors

author

Krzyżanowska Patrycja

author

Lisowska Aleksandra

author

Woś Halina

author

Trawińska-Bartnicka Maria

author

Bober Lyudmyla

author

Rohovyk Nataliya

author

Rachel Marta

author

Walkowiak Jarosław

References

• W alkowiak J, Pogorzelski A, Sands D, i wsp. Zasady rozpoznawania i leczenia mukowiscydozy. Stand Med 2009; 6:352–378.
• McKay KO. Cystic fibrosis: benefits and clinical outcome. J Inherit Metab Dis 2007; 30: 544–555.
• K alnins D, Durie PR, Pencharz P. Nutritional management of cystic fibrosis patients. Curr Opin Clin Nutr Metab Care 2007; 10: 348–354.
• W alkowiak J, Sands D, Nowakowska A, et al. Early decline of pancreatic function in cystic fibrosis patients with class 1 or 2 CFTR mutations. J Pediatr Gastroenterol Nutr 2005; 40: 199–201.
• W alkowiak J, Nousia-Arvanitakis S, Henker J, et al. Indirect pancreatic function tests in children. J Pediatr Gastroenterol Nutr 2005; 40: 107–114.
• Schurgers LJ, Teunissen KJF, Hamulayak K, et al. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood 2007; 109: 3279–3283.
• W ilson DC, Rashio M, Durie PR, et al. Treatment of vitamin K deficiency in cystic fibrosis: effectiveness of a daily fatsoluble vitamin combination. J Pediatr 2001; 138: 851–855.
• Mager DR, McGee PL, Furuya KN, Roberts EA. Prevalence of vitamin K deficiency in children with mild to moderate chronic liver disease. J Pediatr Gastroenterol Nutr 2006; 42: 71–76.
• W atanabe K, Naraki T, Iwasaki Y. Method of determination of PIVKA. Biotechnol Adv 1997; 15: 259.
• Mosler K, Von Kries R, Vermeer C, et al. Assessment of vitamin K deficiency in CF – how much sophistication is useful? J Cyst Fibros 2003; 2: 91–96.
• W ilson DC, Rashid M, Durie PR, et al. Treatment of vitamin K deficiency in cystic fibrosis: effectiveness of a daily fat--soluble vitamin combination. J Pediatr 2001; 138: 851–855.
• R ashid M, Durie P, Andrew M, et al. Prevalence of vitamin K deficiency in cystic fibrosis. Am J Clin Nutr 1999; 70:378–382.
• de Montalembert M, Lenoir G, Saint-Raymond A, et al. Increased PIVKA-II concentrations in patients with cystic fibrosis.J Clin Pathol 1992; 45: 180–181.
• Sokol RJ, Reardon MC, Accurso AJ, et al. Fat-soluble-vitamin status during the first year of life in infants with cystic fibrosis identified by screening of newborns. Am J Clin Nutr 1989; 50: 1064–1071.
• Maqbool A, Stallings VA. Update on fat-soluble vitamins in cystic fibrosis. Curr Opin Pulm Med 2008; 14: 574–581.